PepGen (PEPG) Competitors $1.46 -0.01 (-0.68%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$1.46 0.00 (-0.34%) As of 05/23/2025 06:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PEPG vs. TNXP, CRDF, SOPH, VYGR, YMAB, CRGX, ADCT, SCPH, NBTX, and DMACShould you be buying PepGen stock or one of its competitors? The main competitors of PepGen include Tonix Pharmaceuticals (TNXP), Cardiff Oncology (CRDF), SOPHiA GENETICS (SOPH), Voyager Therapeutics (VYGR), Y-mAbs Therapeutics (YMAB), CARGO Therapeutics (CRGX), ADC Therapeutics (ADCT), scPharmaceuticals (SCPH), Nanobiotix (NBTX), and DiaMedica Therapeutics (DMAC). These companies are all part of the "pharmaceutical products" industry. PepGen vs. Tonix Pharmaceuticals Cardiff Oncology SOPHiA GENETICS Voyager Therapeutics Y-mAbs Therapeutics CARGO Therapeutics ADC Therapeutics scPharmaceuticals Nanobiotix DiaMedica Therapeutics PepGen (NASDAQ:PEPG) and Tonix Pharmaceuticals (NASDAQ:TNXP) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, valuation, community ranking, risk, media sentiment and profitability. Which has more volatility and risk, PEPG or TNXP? PepGen has a beta of 1.39, suggesting that its stock price is 39% more volatile than the S&P 500. Comparatively, Tonix Pharmaceuticals has a beta of 1.63, suggesting that its stock price is 63% more volatile than the S&P 500. Does the MarketBeat Community believe in PEPG or TNXP? Tonix Pharmaceuticals received 320 more outperform votes than PepGen when rated by MarketBeat users. However, 80.77% of users gave PepGen an outperform vote while only 60.68% of users gave Tonix Pharmaceuticals an outperform vote. CompanyUnderperformOutperformPepGenOutperform Votes2180.77% Underperform Votes519.23%Tonix PharmaceuticalsOutperform Votes34160.68% Underperform Votes22139.32% Does the media prefer PEPG or TNXP? In the previous week, PepGen had 1 more articles in the media than Tonix Pharmaceuticals. MarketBeat recorded 4 mentions for PepGen and 3 mentions for Tonix Pharmaceuticals. PepGen's average media sentiment score of 0.44 beat Tonix Pharmaceuticals' score of 0.11 indicating that PepGen is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PepGen 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Tonix Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders & institutionals have more ownership in PEPG or TNXP? 58.0% of PepGen shares are held by institutional investors. Comparatively, 82.3% of Tonix Pharmaceuticals shares are held by institutional investors. 5.2% of PepGen shares are held by insiders. Comparatively, 0.0% of Tonix Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Is PEPG or TNXP more profitable? PepGen has a net margin of 0.00% compared to Tonix Pharmaceuticals' net margin of -1,197.86%. PepGen's return on equity of -60.17% beat Tonix Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets PepGenN/A -60.17% -48.88% Tonix Pharmaceuticals -1,197.86%-163.95%-118.88% Do analysts rate PEPG or TNXP? PepGen currently has a consensus target price of $9.67, indicating a potential upside of 562.10%. Tonix Pharmaceuticals has a consensus target price of $585.00, indicating a potential upside of 1,922.12%. Given Tonix Pharmaceuticals' stronger consensus rating and higher possible upside, analysts clearly believe Tonix Pharmaceuticals is more favorable than PepGen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PepGen 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33Tonix Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable valuation and earnings, PEPG or TNXP? PepGen has higher earnings, but lower revenue than Tonix Pharmaceuticals. PepGen is trading at a lower price-to-earnings ratio than Tonix Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPepGenN/AN/A-$78.63M-$3.13-0.47Tonix Pharmaceuticals$10.04M21.10-$116.66M-$1.96 thousand-0.01 SummaryPepGen beats Tonix Pharmaceuticals on 9 of the 16 factors compared between the two stocks. Get PepGen News Delivered to You Automatically Sign up to receive the latest news and ratings for PEPG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PEPG vs. The Competition Export to ExcelMetricPepGenPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$47.77M$6.46B$5.34B$8.30BDividend YieldN/A2.63%5.27%4.11%P/E Ratio-0.498.4426.9619.59Price / SalesN/A258.50398.81136.02Price / CashN/A65.8538.3234.64Price / Book0.326.416.774.50Net Income-$78.63M$143.95M$3.24B$248.60M7 Day Performance-5.19%0.24%0.27%-0.89%1 Month Performance-4.58%0.37%5.91%7.41%1 Year Performance-89.97%0.56%18.83%8.56% PepGen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PEPGPepGen2.8891 of 5 stars$1.46-0.7%$9.67+562.1%-90.0%$47.77MN/A-0.4930Gap DownTNXPTonix Pharmaceuticals3.2959 of 5 stars$26.60-5.0%$585.00+2,099.2%-94.8%$194.85M$10.04M-0.0150News CoverageAnalyst UpgradeHigh Trading VolumeCRDFCardiff Oncology1.6708 of 5 stars$2.91+3.6%$12.00+312.4%-11.9%$193.59M$587,000.00-3.1020Positive NewsSOPHSOPHiA GENETICS1.7546 of 5 stars$2.86-3.4%$6.80+137.8%-39.7%$190.73M$67.17M-2.62520VYGRVoyager Therapeutics4.6435 of 5 stars$3.43+3.9%$13.39+290.4%-64.5%$189.80M$66.96M4.83100YMABY-mAbs Therapeutics3.4226 of 5 stars$4.17+1.7%$16.60+298.1%-64.6%$188.83M$87.69M-7.72150Analyst RevisionCRGXCARGO Therapeutics2.1638 of 5 stars$4.09-0.7%$15.00+266.7%-80.3%$188.59MN/A-0.96116Positive NewsADCTADC Therapeutics2.7045 of 5 stars$2.34+23.8%$7.75+231.2%-34.4%$187.45M$70.84M-0.98310Gap DownHigh Trading VolumeSCPHscPharmaceuticals4.0686 of 5 stars$3.52+9.3%$14.00+297.7%-5.7%$185.83M$41.98M-1.8530High Trading VolumeNBTXNanobiotix1.6579 of 5 stars$3.94+2.1%$8.00+103.0%-42.4%$185.70M$-11,609,000.000.00100DMACDiaMedica Therapeutics1.4673 of 5 stars$4.27+1.7%$8.00+87.4%+41.0%$183.11MN/A-7.6220Gap DownHigh Trading Volume Related Companies and Tools Related Companies Tonix Pharmaceuticals Alternatives Cardiff Oncology Alternatives SOPHiA GENETICS Alternatives Voyager Therapeutics Alternatives Y-mAbs Therapeutics Alternatives CARGO Therapeutics Alternatives ADC Therapeutics Alternatives scPharmaceuticals Alternatives Nanobiotix Alternatives DiaMedica Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PEPG) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PepGen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PepGen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PEPG Stock Free PEPG Stock Alerts